Skip to main content

Clinical Trials Using Temozolomide

Review the clinical trials studying temozolomide on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 76-83 of 83

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
Status: Temporarily Closed to Accrual
Location: See ClinicalTrials.gov
Pembrolizumab, Olaparib and Temozolomide for the Treatment of Recurrent Glioblastoma
Status: Temporarily Closed to Accrual
Location: 5 locations
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Status: Temporarily Closed to Accrual
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Temporally-Modulated Pulsed Radiation Therapy versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Status: Approved
Location: Location information is not yet available.
Hyperpolarized Imaging in Diagnosing Patients with Glioma
Status: Active
Location: 2 locations
Hyperpolarized Carbon C 13 Pyruvate MRI for the Diagnosis of Patients with Primary Central Nervous System Lymphoma
Status: Active
Location: University of California San Francisco, San Francisco, California
Rapid Infusion of Dinutuximab with Chemotherapy for the Treatment of Relapsed, Refractory or Persistent High Risk Neuroblastoma or Ganglioneuroblastoma
Status: Active
Location: Children's Hospital Los Angeles, Los Angeles, California
Implantable Microdevice for the Delivery of Drugs and their Effect on Tumors in Patients with Sarcoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas